Health
Partnership to Explore Drug Delivery Approaches Labmate Online – Labmate Online
Reagents and therapeutics developer Aptamer Group has extended its existing collaboration with global biopharmaceutical company AstraZeneca to evaluate potential…
Reagents and therapeutics developer Aptamer Group has extended its existing collaboration with global biopharmaceutical company AstraZeneca to evaluate potential use of its Optimer-based strategies to target renal cells and the feasibility of developing next-generation drug delivery conjugates.
Based on oligonucleotide molecules optimers can bind specifically to a target molecule to act as an antibody alternative. Their ability to fold into distinct secondary or tertiary structures gives them high…
-
General12 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
General24 hours ago‘Brumby Bill’ recognising heritage value of wild horses to be scrapped in NSW
-
Noosa News21 hours agoJane Edmanson hangs up her Gardening Australia hat, reflects on labour of love behind show’s success
-
Business23 hours ago3 ASX stocks I’d trust with $10,000 for the next decade